Global Piroxicam Market Size, Status and Forecast 2020-2026

Global Piroxicam Market Size, Status and Forecast 2020-2026

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Piroxicam Revenue
1.4 Market Analysis by Type
1.4.1 Global Piroxicam Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Suppositories
1.4.3 Injection
1.4.4 Capsule
1.4.5 Patch
1.4.6 Other
1.5 Market by Application
1.5.1 Global Piroxicam Market Share by Application: 2020 VS 2026
1.5.2 Tendonitis
1.5.3 Systemic Traumatic Pain
1.5.4 Musculoskeletal Pain
1.5.5 Contraception
1.5.6 Rheumatoid Arthritis
1.5.7 Chronic Infectious Arthritis
1.5.8 Osteoarthritis
1.5.9 Other
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends by Regions
2.1 Piroxicam Market Perspective (2015-2026)
2.2 Piroxicam Growth Trends by Regions
2.2.1 Piroxicam Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Piroxicam Historic Market Share by Regions (2015-2020)
2.2.3 Piroxicam Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter's Five Forces Analysis
2.3.5 Piroxicam Market Growth Strategy
2.3.6 Primary Interviews with Key Piroxicam Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Piroxicam Players by Market Size
3.1.1 Global Top Piroxicam Players by Revenue (2015-2020)
3.1.2 Global Piroxicam Revenue Market Share by Players (2015-2020)
3.1.3 Global Piroxicam Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Piroxicam Market Concentration Ratio
3.2.1 Global Piroxicam Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Piroxicam Revenue in 2019
3.3 Piroxicam Key Players Head office and Area Served
3.4 Key Players Piroxicam Product Solution and Service
3.5 Date of Enter into Piroxicam Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Piroxicam Historic Market Size by Type (2015-2020)
4.2 Global Piroxicam Forecasted Market Size by Type (2021-2026)
5 Piroxicam Breakdown Data by Application (2015-2026)
5.1 Global Piroxicam Market Size by Application (2015-2020)
5.2 Global Piroxicam Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Piroxicam Market Size (2015-2020)
6.2 Piroxicam Key Players in North America (2019-2020)
6.3 North America Piroxicam Market Size by Type (2015-2020)
6.4 North America Piroxicam Market Size by Application (2015-2020)
7 Europe
7.1 Europe Piroxicam Market Size (2015-2020)
7.2 Piroxicam Key Players in Europe (2019-2020)
7.3 Europe Piroxicam Market Size by Type (2015-2020)
7.4 Europe Piroxicam Market Size by Application (2015-2020)
8 China
8.1 China Piroxicam Market Size (2015-2020)
8.2 Piroxicam Key Players in China (2019-2020)
8.3 China Piroxicam Market Size by Type (2015-2020)
8.4 China Piroxicam Market Size by Application (2015-2020)
9 Japan
9.1 Japan Piroxicam Market Size (2015-2020)
9.2 Piroxicam Key Players in Japan (2019-2020)
9.3 Japan Piroxicam Market Size by Type (2015-2020)
9.4 Japan Piroxicam Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Piroxicam Market Size (2015-2020)
10.2 Piroxicam Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Piroxicam Market Size by Type (2015-2020)
10.4 Southeast Asia Piroxicam Market Size by Application (2015-2020)
11 India
11.1 India Piroxicam Market Size (2015-2020)
11.2 Piroxicam Key Players in India (2019-2020)
11.3 India Piroxicam Market Size by Type (2015-2020)
11.4 India Piroxicam Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Piroxicam Market Size (2015-2020)
12.2 Piroxicam Key Players in Central & South America (2019-2020)
12.3 Central & South America Piroxicam Market Size by Type (2015-2020)
12.4 Central & South America Piroxicam Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Pfizer
13.1.1 Pfizer Company Details
13.1.2 Pfizer Business Overview and Its Total Revenue
13.1.3 Pfizer Piroxicam Introduction
13.1.4 Pfizer Revenue in Piroxicam Business (2015-2020))
13.1.5 Pfizer Recent Development
13.2 Teva
13.2.1 Teva Company Details
13.2.2 Teva Business Overview and Its Total Revenue
13.2.3 Teva Piroxicam Introduction
13.2.4 Teva Revenue in Piroxicam Business (2015-2020)
13.2.5 Teva Recent Development
13.3 Mylan
13.3.1 Mylan Company Details
13.3.2 Mylan Business Overview and Its Total Revenue
13.3.3 Mylan Piroxicam Introduction
13.3.4 Mylan Revenue in Piroxicam Business (2015-2020)
13.3.5 Mylan Recent Development
13.4 Nostrum
13.4.1 Nostrum Company Details
13.4.2 Nostrum Business Overview and Its Total Revenue
13.4.3 Nostrum Piroxicam Introduction
13.4.4 Nostrum Revenue in Piroxicam Business (2015-2020)
13.4.5 Nostrum Recent Development
13.5 DCPC
13.5.1 DCPC Company Details
13.5.2 DCPC Business Overview and Its Total Revenue
13.5.3 DCPC Piroxicam Introduction
13.5.4 DCPC Revenue in Piroxicam Business (2015-2020)
13.5.5 DCPC Recent Development
13.6 FANGMING
13.6.1 FANGMING Company Details
13.6.2 FANGMING Business Overview and Its Total Revenue
13.6.3 FANGMING Piroxicam Introduction
13.6.4 FANGMING Revenue in Piroxicam Business (2015-2020)
13.6.5 FANGMING Recent Development
13.7 JINGHUA
13.7.1 JINGHUA Company Details
13.7.2 JINGHUA Business Overview and Its Total Revenue
13.7.3 JINGHUA Piroxicam Introduction
13.7.4 JINGHUA Revenue in Piroxicam Business (2015-2020)
13.7.5 JINGHUA Recent Development
13.8 JUMPCAN
13.8.1 JUMPCAN Company Details
13.8.2 JUMPCAN Business Overview and Its Total Revenue
13.8.3 JUMPCAN Piroxicam Introduction
13.8.4 JUMPCAN Revenue in Piroxicam Business (2015-2020)
13.8.5 JUMPCAN Recent Development
13.9 Technilab Pharma
13.9.1 Technilab Pharma Company Details
13.9.2 Technilab Pharma Business Overview and Its Total Revenue
13.9.3 Technilab Pharma Piroxicam Introduction
13.9.4 Technilab Pharma Revenue in Piroxicam Business (2015-2020)
13.9.5 Technilab Pharma Recent Development
13.10 Apotex Corporation
13.10.1 Apotex Corporation Company Details
13.10.2 Apotex Corporation Business Overview and Its Total Revenue
13.10.3 Apotex Corporation Piroxicam Introduction
13.10.4 Apotex Corporation Revenue in Piroxicam Business (2015-2020)
13.10.5 Apotex Corporation Recent Development
13.11 Keltman Pharmaceuticals
10.11.1 Keltman Pharmaceuticals Company Details
10.11.2 Keltman Pharmaceuticals Business Overview and Its Total Revenue
10.11.3 Keltman Pharmaceuticals Piroxicam Introduction
10.11.4 Keltman Pharmaceuticals Revenue in Piroxicam Business (2015-2020)
10.11.5 Keltman Pharmaceuticals Recent Development
13.12 Genpharm
10.12.1 Genpharm Company Details
10.12.2 Genpharm Business Overview and Its Total Revenue
10.12.3 Genpharm Piroxicam Introduction
10.12.4 Genpharm Revenue in Piroxicam Business (2015-2020)
10.12.5 Genpharm Recent Development
13.13 Bayer
10.13.1 Bayer Company Details
10.13.2 Bayer Business Overview and Its Total Revenue
10.13.3 Bayer Piroxicam Introduction
10.13.4 Bayer Revenue in Piroxicam Business (2015-2020)
10.13.5 Bayer Recent Development
13.14 PLX Pharma
10.14.1 PLX Pharma Company Details
10.14.2 PLX Pharma Business Overview and Its Total Revenue
10.14.3 PLX Pharma Piroxicam Introduction
10.14.4 PLX Pharma Revenue in Piroxicam Business (2015-2020)
10.14.5 PLX Pharma Recent Development
13.15 Chiesi
10.15.1 Chiesi Company Details
10.15.2 Chiesi Business Overview and Its Total Revenue
10.15.3 Chiesi Piroxicam Introduction
10.15.4 Chiesi Revenue in Piroxicam Business (2015-2020)
10.15.5 Chiesi Recent Development
13.16 SK Chemicals
10.16.1 SK Chemicals Company Details
10.16.2 SK Chemicals Business Overview and Its Total Revenue
10.16.3 SK Chemicals Piroxicam Introduction
10.16.4 SK Chemicals Revenue in Piroxicam Business (2015-2020)
10.16.5 SK Chemicals Recent Development
13.17 Bioglan Laboratories
10.17.1 Bioglan Laboratories Company Details
10.17.2 Bioglan Laboratories Business Overview and Its Total Revenue
10.17.3 Bioglan Laboratories Piroxicam Introduction
10.17.4 Bioglan Laboratories Revenue in Piroxicam Business (2015-2020)
10.17.5 Bioglan Laboratories Recent Development
13.18 APR
10.18.1 APR Company Details
10.18.2 APR Business Overview and Its Total Revenue
10.18.3 APR Piroxicam Introduction
10.18.4 APR Revenue in Piroxicam Business (2015-2020)
10.18.5 APR Recent Development
13.19 CJ HealthCare
10.19.1 CJ HealthCare Company Details
10.19.2 CJ HealthCare Business Overview and Its Total Revenue
10.19.3 CJ HealthCare Piroxicam Introduction
10.19.4 CJ HealthCare Revenue in Piroxicam Business (2015-2020)
10.19.5 CJ HealthCare Recent Development
13.20 SkyePharma
10.20.1 SkyePharma Company Details
10.20.2 SkyePharma Business Overview and Its Total Revenue
10.20.3 SkyePharma Piroxicam Introduction
10.20.4 SkyePharma Revenue in Piroxicam Business (2015-2020)
10.20.5 SkyePharma Recent Development
13.21 Changzhou Siyao Pharmaceutical
10.21.1 Changzhou Siyao Pharmaceutical Company Details
10.21.2 Changzhou Siyao Pharmaceutical Business Overview and Its Total Revenue
10.21.3 Changzhou Siyao Pharmaceutical Piroxicam Introduction
10.21.4 Changzhou Siyao Pharmaceutical Revenue in Piroxicam Business (2015-2020)
10.21.5 Changzhou Siyao Pharmaceutical Recent Development
13.22 Shanxi Yunpeng Pharmaceutical
10.22.1 Shanxi Yunpeng Pharmaceutical Company Details
10.22.2 Shanxi Yunpeng Pharmaceutical Business Overview and Its Total Revenue
10.22.3 Shanxi Yunpeng Pharmaceutical Piroxicam Introduction
10.22.4 Shanxi Yunpeng Pharmaceutical Revenue in Piroxicam Business (2015-2020)
10.22.5 Shanxi Yunpeng Pharmaceutical Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Tables
Table 1. Piroxicam Key Market Segments
Table 2. Key Players Covered: Ranking by Piroxicam Revenue
Table 3. Ranking of Global Top Piroxicam Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Piroxicam Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Suppositories
Table 6. Key Players of Injection
Table 7. Key Players of Capsule
Table 8. Key Players of Patch
Table 9. Key Players of Other
Table 10. Global Piroxicam Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 11. Global Piroxicam Market Size by Regions (US$ Million): 2020 VS 2026
Table 12. Global Piroxicam Market Size by Regions (2015-2020) (US$ Million)
Table 13. Global Piroxicam Market Share by Regions (2015-2020)
Table 14. Global Piroxicam Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 15. Global Piroxicam Market Share by Regions (2021-2026)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. Piroxicam Market Growth Strategy
Table 20. Main Points Interviewed from Key Piroxicam Players
Table 21. Global Piroxicam Revenue by Players (2015-2020) (Million US$)
Table 22. Global Piroxicam Market Share by Players (2015-2020)
Table 23. Global Top Piroxicam Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Piroxicam as of 2019)
Table 24. Global Piroxicam by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Piroxicam Product Solution and Service
Table 27. Date of Enter into Piroxicam Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Piroxicam Market Size by Type (2015-2020) (Million US$)
Table 30. Global Piroxicam Market Size Share by Type (2015-2020)
Table 31. Global Piroxicam Revenue Market Share by Type (2021-2026)
Table 32. Global Piroxicam Market Size Share by Application (2015-2020)
Table 33. Global Piroxicam Market Size by Application (2015-2020) (Million US$)
Table 34. Global Piroxicam Market Size Share by Application (2021-2026)
Table 35. North America Key Players Piroxicam Revenue (2019-2020) (Million US$)
Table 36. North America Key Players Piroxicam Market Share (2019-2020)
Table 37. North America Piroxicam Market Size by Type (2015-2020) (Million US$)
Table 38. North America Piroxicam Market Share by Type (2015-2020)
Table 39. North America Piroxicam Market Size by Application (2015-2020) (Million US$)
Table 40. North America Piroxicam Market Share by Application (2015-2020)
Table 41. Europe Key Players Piroxicam Revenue (2019-2020) (Million US$)
Table 42. Europe Key Players Piroxicam Market Share (2019-2020)
Table 43. Europe Piroxicam Market Size by Type (2015-2020) (Million US$)
Table 44. Europe Piroxicam Market Share by Type (2015-2020)
Table 45. Europe Piroxicam Market Size by Application (2015-2020) (Million US$)
Table 46. Europe Piroxicam Market Share by Application (2015-2020)
Table 47. China Key Players Piroxicam Revenue (2019-2020) (Million US$)
Table 48. China Key Players Piroxicam Market Share (2019-2020)
Table 49. China Piroxicam Market Size by Type (2015-2020) (Million US$)
Table 50. China Piroxicam Market Share by Type (2015-2020)
Table 51. China Piroxicam Market Size by Application (2015-2020) (Million US$)
Table 52. China Piroxicam Market Share by Application (2015-2020)
Table 53. Japan Key Players Piroxicam Revenue (2019-2020) (Million US$)
Table 54. Japan Key Players Piroxicam Market Share (2019-2020)
Table 55. Japan Piroxicam Market Size by Type (2015-2020) (Million US$)
Table 56. Japan Piroxicam Market Share by Type (2015-2020)
Table 57. Japan Piroxicam Market Size by Application (2015-2020) (Million US$)
Table 58. Japan Piroxicam Market Share by Application (2015-2020)
Table 59. Southeast Asia Key Players Piroxicam Revenue (2019-2020) (Million US$)
Table 60. Southeast Asia Key Players Piroxicam Market Share (2019-2020)
Table 61. Southeast Asia Piroxicam Market Size by Type (2015-2020) (Million US$)
Table 62. Southeast Asia Piroxicam Market Share by Type (2015-2020)
Table 63. Southeast Asia Piroxicam Market Size by Application (2015-2020) (Million US$)
Table 64. Southeast Asia Piroxicam Market Share by Application (2015-2020)
Table 65. India Key Players Piroxicam Revenue (2019-2020) (Million US$)
Table 66. India Key Players Piroxicam Market Share (2019-2020)
Table 67. India Piroxicam Market Size by Type (2015-2020) (Million US$)
Table 68. India Piroxicam Market Share by Type (2015-2020)
Table 69. India Piroxicam Market Size by Application (2015-2020) (Million US$)
Table 70. India Piroxicam Market Share by Application (2015-2020)
Table 71. Central & South America Key Players Piroxicam Revenue (2019-2020) (Million US$)
Table 72. Central & South America Key Players Piroxicam Market Share (2019-2020)
Table 73. Central & South America Piroxicam Market Size by Type (2015-2020) (Million US$)
Table 74. Central & South America Piroxicam Market Share by Type (2015-2020)
Table 75. Central & South America Piroxicam Market Size by Application (2015-2020) (Million US$)
Table 76. Central & South America Piroxicam Market Share by Application (2015-2020)
Table 77. Pfizer Company Details
Table 78. Pfizer Business Overview
Table 79. Pfizer Product
Table 80. Pfizer Revenue in Piroxicam Business (2015-2020) (Million US$)
Table 81. Pfizer Recent Development
Table 82. Teva Company Details
Table 83. Teva Business Overview
Table 84. Teva Product
Table 85. Teva Revenue in Piroxicam Business (2015-2020) (Million US$)
Table 86. Teva Recent Development
Table 87. Mylan Company Details
Table 88. Mylan Business Overview
Table 89. Mylan Product
Table 90. Mylan Revenue in Piroxicam Business (2015-2020) (Million US$)
Table 91. Mylan Recent Development
Table 92. Nostrum Company Details
Table 93. Nostrum Business Overview
Table 94. Nostrum Product
Table 95. Nostrum Revenue in Piroxicam Business (2015-2020) (Million US$)
Table 96. Nostrum Recent Development
Table 97. DCPC Company Details
Table 98. DCPC Business Overview
Table 99. DCPC Product
Table 100. DCPC Revenue in Piroxicam Business (2015-2020) (Million US$)
Table 101. DCPC Recent Development
Table 102. FANGMING Company Details
Table 103. FANGMING Business Overview
Table 104. FANGMING Product
Table 105. FANGMING Revenue in Piroxicam Business (2015-2020) (Million US$)
Table 106. FANGMING Recent Development
Table 107. JINGHUA Company Details
Table 108. JINGHUA Business Overview
Table 109. JINGHUA Product
Table 110. JINGHUA Revenue in Piroxicam Business (2015-2020) (Million US$)
Table 111. JINGHUA Recent Development
Table 112. JUMPCAN Business Overview
Table 113. JUMPCAN Product
Table 114. JUMPCAN Company Details
Table 115. JUMPCAN Revenue in Piroxicam Business (2015-2020) (Million US$)
Table 116. JUMPCAN Recent Development
Table 117. Technilab Pharma Company Details
Table 118. Technilab Pharma Business Overview
Table 119. Technilab Pharma Product
Table 120. Technilab Pharma Revenue in Piroxicam Business (2015-2020) (Million US$)
Table 121. Technilab Pharma Recent Development
Table 122. Apotex Corporation Company Details
Table 123. Apotex Corporation Business Overview
Table 124. Apotex Corporation Product
Table 125. Apotex Corporation Revenue in Piroxicam Business (2015-2020) (Million US$)
Table 126. Apotex Corporation Recent Development
Table 127. Keltman Pharmaceuticals Company Details
Table 128. Keltman Pharmaceuticals Business Overview
Table 129. Keltman Pharmaceuticals Product
Table 130. Keltman Pharmaceuticals Revenue in Piroxicam Business (2015-2020) (Million US$)
Table 131. Keltman Pharmaceuticals Recent Development
Table 132. Genpharm Company Details
Table 133. Genpharm Business Overview
Table 134. Genpharm Product
Table 135. Genpharm Revenue in Piroxicam Business (2015-2020) (Million US$)
Table 136. Genpharm Recent Development
Table 137. Bayer Company Details
Table 138. Bayer Business Overview
Table 139. Bayer Product
Table 140. Bayer Revenue in Piroxicam Business (2015-2020) (Million US$)
Table 141. Bayer Recent Development
Table 142. PLX Pharma Company Details
Table 143. PLX Pharma Business Overview
Table 144. PLX Pharma Product
Table 145. PLX Pharma Revenue in Piroxicam Business (2015-2020) (Million US$)
Table 146. PLX Pharma Recent Development
Table 147. Chiesi Company Details
Table 148. Chiesi Business Overview
Table 149. Chiesi Product
Table 150. Chiesi Revenue in Piroxicam Business (2015-2020) (Million US$)
Table 151. Chiesi Recent Development
Table 152. SK Chemicals Company Details
Table 153. SK Chemicals Business Overview
Table 154. SK Chemicals Product
Table 155. SK Chemicals Revenue in Piroxicam Business (2015-2020) (Million US$)
Table 156. SK Chemicals Recent Development
Table 157. Bioglan Laboratories Company Details
Table 158. Bioglan Laboratories Business Overview
Table 159. Bioglan Laboratories Product
Table 160. Bioglan Laboratories Revenue in Piroxicam Business (2015-2020) (Million US$)
Table 161. Bioglan Laboratories Recent Development
Table 162. APR Company Details
Table 163. APR Business Overview
Table 164. APR Product
Table 165. APR Revenue in Piroxicam Business (2015-2020) (Million US$)
Table 166. APR Recent Development
Table 167. CJ HealthCare Company Details
Table 168. CJ HealthCare Business Overview
Table 169. CJ HealthCare Product
Table 170. CJ HealthCare Revenue in Piroxicam Business (2015-2020) (Million US$)
Table 171. CJ HealthCare Recent Development
Table 172. SkyePharma Company Details
Table 173. SkyePharma Business Overview
Table 174. SkyePharma Product
Table 175. SkyePharma Revenue in Piroxicam Business (2015-2020) (Million US$)
Table 176. SkyePharma Recent Development
Table 177. Changzhou Siyao Pharmaceutical Company Details
Table 178. Changzhou Siyao Pharmaceutical Business Overview
Table 179. Changzhou Siyao Pharmaceutical Product
Table 180. Changzhou Siyao Pharmaceutical Revenue in Piroxicam Business (2015-2020) (Million US$)
Table 181. Changzhou Siyao Pharmaceutical Recent Development
Table 182. Shanxi Yunpeng Pharmaceutical Company Details
Table 183. Shanxi Yunpeng Pharmaceutical Business Overview
Table 184. Shanxi Yunpeng Pharmaceutical Product
Table 185. Shanxi Yunpeng Pharmaceutical Revenue in Piroxicam Business (2015-2020) (Million US$)
Table 186. Shanxi Yunpeng Pharmaceutical Recent Development
Table 187. Research Programs/Design for This Report
Table 188. Key Data Information from Secondary Sources
Table 189. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Piroxicam Market Share by Type: 2020 VS 2026
Figure 2. Suppositories Features
Figure 3. Injection Features
Figure 4. Capsule Features
Figure 5. Patch Features
Figure 6. Other Features
Figure 7. Global Piroxicam Market Share by Application: 2020 VS 2026
Figure 8. Tendonitis Case Studies
Figure 9. Systemic Traumatic Pain Case Studies
Figure 10. Musculoskeletal Pain Case Studies
Figure 11. Contraception Case Studies
Figure 12. Rheumatoid Arthritis Case Studies
Figure 13. Chronic Infectious Arthritis Case Studies
Figure 14. Osteoarthritis Case Studies
Figure 15. Other Case Studies
Figure 16. Piroxicam Report Years Considered
Figure 17. Global Piroxicam Market Size YoY Growth 2015-2026 (US$ Million)
Figure 18. Global Piroxicam Market Share by Regions: 2020 VS 2026
Figure 19. Global Piroxicam Market Share by Regions (2021-2026)
Figure 20. Porter's Five Forces Analysis
Figure 21. Global Piroxicam Market Share by Players in 2019
Figure 22. Global Top Piroxicam Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Piroxicam as of 2019
Figure 23. The Top 10 and 5 Players Market Share by Piroxicam Revenue in 2019
Figure 24. North America Piroxicam Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Europe Piroxicam Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. China Piroxicam Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Japan Piroxicam Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. Southeast Asia Piroxicam Market Size YoY Growth (2015-2020) (Million US$)
Figure 29. India Piroxicam Market Size YoY Growth (2015-2020) (Million US$)
Figure 30. Central & South America Piroxicam Market Size YoY Growth (2015-2020) (Million US$)
Figure 31. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Pfizer Revenue Growth Rate in Piroxicam Business (2015-2020)
Figure 33. Teva Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Teva Revenue Growth Rate in Piroxicam Business (2015-2020)
Figure 35. Mylan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Mylan Revenue Growth Rate in Piroxicam Business (2015-2020)
Figure 37. Nostrum Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Nostrum Revenue Growth Rate in Piroxicam Business (2015-2020)
Figure 39. DCPC Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. DCPC Revenue Growth Rate in Piroxicam Business (2015-2020)
Figure 41. FANGMING Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. FANGMING Revenue Growth Rate in Piroxicam Business (2015-2020)
Figure 43. JINGHUA Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. JINGHUA Revenue Growth Rate in Piroxicam Business (2015-2020)
Figure 45. JUMPCAN Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. JUMPCAN Revenue Growth Rate in Piroxicam Business (2015-2020)
Figure 47. Technilab Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 48. Technilab Pharma Revenue Growth Rate in Piroxicam Business (2015-2020)
Figure 49. Apotex Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Apotex Corporation Revenue Growth Rate in Piroxicam Business (2015-2020)
Figure 51. Keltman Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Keltman Pharmaceuticals Revenue Growth Rate in Piroxicam Business (2015-2020)
Figure 53. Genpharm Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Genpharm Revenue Growth Rate in Piroxicam Business (2015-2020)
Figure 55. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Bayer Revenue Growth Rate in Piroxicam Business (2015-2020)
Figure 57. PLX Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. PLX Pharma Revenue Growth Rate in Piroxicam Business (2015-2020)
Figure 59. Chiesi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Chiesi Revenue Growth Rate in Piroxicam Business (2015-2020)
Figure 61. SK Chemicals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. SK Chemicals Revenue Growth Rate in Piroxicam Business (2015-2020)
Figure 63. Bioglan Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 64. Bioglan Laboratories Revenue Growth Rate in Piroxicam Business (2015-2020)
Figure 65. APR Total Revenue (US$ Million): 2019 Compared with 2018
Figure 66. APR Revenue Growth Rate in Piroxicam Business (2015-2020)
Figure 67. CJ HealthCare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 68. CJ HealthCare Revenue Growth Rate in Piroxicam Business (2015-2020)
Figure 69. SkyePharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 70. SkyePharma Revenue Growth Rate in Piroxicam Business (2015-2020)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Methylprednisolone Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

Methylprednisolone is a corticosteroid medication used to reduce inflammation and suppress The immune system. It is prescribed for a wide range of medical conditions, including autoimmune disorders and inflammatory diseases. The global Methylprednisolone market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. Methylprednisolone is a widely used medication, and The market trend invol......

Global Ibuprofen Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 84

Ibuprofen is an API which is used to produce ibuprofen drugs. Finished drugs ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) derivative of propionic acid used for relieving pain, helping with fever and reducing inflammation. The global Ibuprofen market was valued at US$ 93 million in 2023 and is anticipated to reach US$ 112.3 million by 2030, witnessing a CAGR of 2.7% during The forecast period 2024-2030. Market competition is intense. Xinhua Pharmaceutical, IOLCP,......

Global Mesalazine Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 132

According to our LPI (LP Information) latest study, the global Mesalazine market size was valued at US$ 158.3 million in 2023. With growing demand in downstream market, the Mesalazine is forecast to a readjusted size of US$ 206 million by 2030 with a CAGR of 3.8% during review period. The research report highlights the growth potential of the global Mesalazine market. Mesalazine are expected to show stable growth in the future market. However, product differentiation, reducing costs, and......

Global Drugs For Sinusitis Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 109

According to our LPI (LP Information) latest study, the global Drugs For Sinusitis market size was valued at US$ 2187.4 million in 2023. With growing demand in downstream market, the Drugs For Sinusitis is forecast to a readjusted size of US$ 2827.4 million by 2030 with a CAGR of 3.7% during review period. The research report highlights the growth potential of the global Drugs For Sinusitis market. Drugs For Sinusitis are expected to show stable growth in the future market. However, prod......

Global Celecoxib Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 94

According to our LPI (LP Information) latest study, the global Celecoxib market size was valued at US$ 1243.6 million in 2023. With growing demand in downstream market, the Celecoxib is forecast to a readjusted size of US$ 2232 million by 2030 with a CAGR of 8.7% during review period. The research report highlights the growth potential of the global Celecoxib market. Celecoxib are expected to show stable growth in the future market. However, product differentiation, reducing costs, and s......

Global Ibuprofen Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 100

According to our LPI (LP Information) latest study, the global Ibuprofen market size was valued at US$ 91 million in 2023. With growing demand in downstream market, the Ibuprofen is forecast to a readjusted size of US$ 110.4 million by 2030 with a CAGR of 2.8% during review period. The research report highlights the growth potential of the global Ibuprofen market. Ibuprofen are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supp......

Global Ketoprofen Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 94

According to our LPI (LP Information) latest study, the global Ketoprofen market size was valued at US$ 34 million in 2023. With growing demand in downstream market, the Ketoprofen is forecast to a readjusted size of US$ 39 million by 2030 with a CAGR of 2.0% during review period. The research report highlights the growth potential of the global Ketoprofen market. Ketoprofen are expected to show stable growth in the future market. However, product differentiation, reducing costs, and sup......

Global Drugs for Sinusitis Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 02-Jan-2024        Price: US 3380 Onwards        Pages: 114

Market Overview of Global Drugs for Sinusitis market: According to our latest research, the global Drugs for Sinusitis market looks promising in the next 5 years. As of 2022, the global Drugs for Sinusitis market was estimated at USD 2147.6 million, and it's anticipated to reach USD 3206.59 million in 2028, with a CAGR of 6.91% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Dru......

Global Ibuprofen Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 91

According to our (Global Info Research) latest study, the global Ibuprofen market size was valued at USD 96 million in 2023 and is forecast to a readjusted size of USD 114.4 million by 2030 with a CAGR of 2.6% during review period. Ibuprofen is an API which is used to produce ibuprofen drugs. Finished drugs ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) derivative of propionic acid used for relieving pain, helping with fever and reducing inflammation. Market competitio......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs